- Research works
- 37 ▼ 62% vs 2013–17
- Citations
- 1.6k 43.5 per fractional work
- Top-10% rate
- 13.4% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Covance (Australia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 9.1×. Every wedge is a field page.
Which keywords describe research at Covance (Australia)?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Clinical Trials, Pharmaceutical Industry, Bayesian Inference, Metastatic Breast Cancer and Drug Development Costs.
- Oxidative Stress
- Taxanes
- Prostate Cancer
- Clinical Practice Guidelines
- Cancer Treatment
- Inflammation
- Cost of Care
- Generic Drugs
- Bayesian Inference
- Pharmaceutical Industry
- Epidemiology
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Clinical Trials
- Treatment
- Drug Development Costs
- Metastatic Breast Cancer
- Financial Toxicity
- Biomarkers
- Chemotherapy-Induced Peripheral Neuropathy
- Immunotherapy
- Targeted Therapy
- Global Burden
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Quality of Life5▲ 9.3×6 topics
- Cost-effectiveness Analysis3▲ 103×1 topic
- Health Utility Measures3▲ 103×1 topic
- Epidemiology3▲ 1.72×19 topics
- Clinical Trials2▲ 8.4×9 topics
- Pharmaceutical Industry2▲ 127×2 topics
- Treatment2▲ 3.5×10 topics
- Bayesian Inference2▲ 33×2 topics
- Drug Development Costs2▲ 155×1 topic
- Generic Drugs2▲ 155×1 topic
- Metastatic Breast Cancer2▲ 62×2 topics
- Cost of Care1▲ 203×1 topic
- Financial Toxicity1▲ 203×1 topic
- Inflammation1▲ 1.61×10 topics
- Biomarkers1▲ 5.5×3 topics
- Cancer Treatment1▲ 14×3 topics
- Chemotherapy-Induced Peripheral Neuropathy1▲ 61×1 topic
- Clinical Practice Guidelines1▲ 5.4×6 topics
- Immunotherapy1▲ 4.5×4 topics
- Prostate Cancer1▲ 20×2 topics
- Targeted Therapy1▲ 14×4 topics
- Taxanes1▲ 61×1 topic
- Global Burden1▲ 5.0×4 topics
- Oxidative Stress1▲ 1.52×5 topics
Which research topics does Covance (Australia) publish most on?
By volume in 2022–2025: Online Learning and Analytics, Economic and Financial Impacts of Cancer, Online and Blended Learning and Cancer Treatment and Pharmacology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Online Learning and Analytics Computer Science Applications 0 works
- 2 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 3 Online and Blended Learning Education 0 works
- 4 Cancer Treatment and Pharmacology Oncology 0 works
- 5 Innovative Teaching and Learning Methods Developmental and Educational Psychology 0 works
- 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 7 Landfill Environmental Impact Studies Industrial and Manufacturing Engineering 0 works
- 8 Polysaccharides and Plant Cell Walls Plant Science 0 works
- 9 Proteins in Food Systems Food Science 0 works
- 10 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Covance (Australia)'s research output changed?
Output in 2018–2022 was 62% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in North Ryde
- ARC Centre of Excellence for Core to Crust Fluid Systems
- Boehringer Ingelheim (Australia)
- Canon (Australia)
- Smith & Nephew (Australia)
- Honeywell (Australia)
- Aristocrat (Australia)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.